TLRY
Tilray Brands Inc
NASDAQ · Pharmaceuticals
$7.58
+0.53 (+7.52%)
Open$7.20
Previous Close$7.05
Day High$7.65
Day Low$7.16
52W High$23.20
52W Low$3.51
Volume—
Avg Volume3.66M
Market Cap883.12M
P/E Ratio—
EPS$-2.58
SectorPharmaceuticals
Analyst Ratings
Hold
16 analysts
Price Target
+458.3% upside
Current
$7.58
$7.58
Target
$42.32
$42.32
$27.22
$42.32 avg
$56.32
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 107.48M | 98.30M | 199.10M |
| Net Income | -286,152,641 | -235,538,116 | 47.16M |
| Profit Margin | -266.3% | -252.9% | 23.7% |
| EBITDA | -283,472,982 | -246,295,347 | 106.10M |
| Free Cash Flow | — | — | 63.55M |
| Rev Growth | +9.3% | +9.3% | +4.2% |
| Debt/Equity | 0.20 | 0.20 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |